-
1
-
-
40749143143
-
Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria
-
Matutes E, Oscier D, Montalban C, et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia. 2008;22:487-495.
-
(2008)
Leukemia.
, vol.22
, pp. 487-495
-
-
Matutes, E.1
Oscier, D.2
Montalban, C.3
-
2
-
-
79961006284
-
Marginal zone lymphomas with plasmacytic differentiation and related disorders
-
Molina TJ, Lin P, Swerdlow SH, et al. Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Pathol. 2011;136:211-225.
-
(2011)
Am J Clin Pathol.
, vol.136
, pp. 211-225
-
-
Molina, T.J.1
Lin, P.2
Swerdlow, S.H.3
-
4
-
-
20444441543
-
Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: Are they distinct or the same entity?
-
Berger F, Traverse-Glehen A, Felman P, et al. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Clin Lymphoma. 2005;5:220-224.
-
(2005)
Clin Lymphoma.
, vol.5
, pp. 220-224
-
-
Berger, F.1
Traverse-Glehen, A.2
Felman, P.3
-
5
-
-
79551686422
-
Oncogenically active MYD88 mutations in human lymphoma
-
Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature. 2011;470:115-119.
-
(2011)
Nature.
, vol.470
, pp. 115-119
-
-
Ngo, V.N.1
Young, R.M.2
Schmitz, R.3
-
6
-
-
84877343691
-
MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction
-
Xu L, Hunter ZR, Yang G, et al. MYD88 L265P in Waldenstrom macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood. 2013;121:2051-2058.
-
(2013)
Blood.
, vol.121
, pp. 2051-2058
-
-
Xu, L.1
Hunter, Z.R.2
Yang, G.3
-
7
-
-
84865475885
-
MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia
-
Treon SP, Xu L, Yang G, et al. MYD88 L265P somatic mutation in Waldenstrom's macroglobulinemia. N Engl JMed. 2012;367:826-833.
-
(2012)
N Engl JMed.
, vol.367
, pp. 826-833
-
-
Treon, S.P.1
Xu, L.2
Yang, G.3
-
8
-
-
84879404052
-
MYD88 L265P mutation in Waldenstrom macroglobulinemia
-
Poulain S, Roumier C, Decambron A, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121:4504-4511.
-
(2013)
Blood.
, vol.121
, pp. 4504-4511
-
-
Poulain, S.1
Roumier, C.2
Decambron, A.3
-
9
-
-
84881482021
-
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia
-
Jimenez C, Sebastian E, Chillon MC, et al. MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenstrom's macroglobulinemia. Leukemia. 2013;27:1722-1728.
-
(2013)
Leukemia.
, vol.27
, pp. 1722-1728
-
-
Jimenez, C.1
Sebastian, E.2
Chillon, M.C.3
-
10
-
-
84878423649
-
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms
-
Varettoni M, Arcaini L, Zibellini S, et al. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood. 2013;121:2522-2528.
-
(2013)
Blood.
, vol.121
, pp. 2522-2528
-
-
Varettoni, M.1
Arcaini, L.2
Zibellini, S.3
-
11
-
-
84887396799
-
MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance
-
Varettoni M, Zibellini S, Arcaini L, et al. MYD88 (L265P) mutation is an independent risk factor for progression in patients with IgM monoclonal gammopathy of undetermined significance. Blood. 2013;122:2284-2285.
-
(2013)
Blood.
, vol.122
, pp. 2284-2285
-
-
Varettoni, M.1
Zibellini, S.2
Arcaini, L.3
-
12
-
-
13244253874
-
Lymphoid neoplasm associated with IgM paraprotein. A study of 382 patients
-
Lin P, Hao S, Handy BC, et al. Lymphoid neoplasm associated with IgM paraprotein. A study of 382 patients. Am J Clin Pathol. 2005;123:200-205.
-
(2005)
Am J Clin Pathol.
, vol.123
, pp. 200-205
-
-
Lin, P.1
Hao, S.2
Handy, B.C.3
-
13
-
-
0034208482
-
Clinicopathological correlates of IgM paraproteinemias
-
discussion 4-5
-
Owen RG, Parapia LA, Higginson J, et al. Clinicopathological correlates of IgM paraproteinemias. Clin Lymphoma. 2000;1:39-43; discussion 4-5.
-
(2000)
Clin Lymphoma.
, vol.1
, pp. 39-43
-
-
Owen, R.G.1
Parapia, L.A.2
Higginson, J.3
-
14
-
-
0023240678
-
The spectrum of IgM monoclonal gammopathy in 430 cases
-
Kyle RA, Garton JP. The spectrum of IgM monoclonal gammopathy in 430 cases. Mayo Clin Proc. 1987;62:719-731.
-
(1987)
Mayo Clin Proc.
, vol.62
, pp. 719-731
-
-
Kyle, R.A.1
Garton, J.P.2
-
15
-
-
84873568405
-
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas
-
Gachard N, Parrens M, Soubeyran I, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 2013;27:183-189.
-
(2013)
Leukemia.
, vol.27
, pp. 183-189
-
-
Gachard, N.1
Parrens, M.2
Soubeyran, I.3
-
16
-
-
84865167399
-
MYD88 somatic mutations in MALT lymphomas
-
Li ZM, Rinaldi A, Cavalli A, et al. MYD88 somatic mutations in MALT lymphomas. Br J Haematol. 2012;158:662-664.
-
(2012)
Br J Haematol.
, vol.158
, pp. 662-664
-
-
Li, Z.M.1
Rinaldi, A.2
Cavalli, A.3
-
17
-
-
85060361523
-
MYD88 mutation anlysis helps define nodal lymphoplasmacytic lymphoma
-
Epub ahead of print
-
Hamadeh F, MacNamara SP, Aguilera NS, et al. MYD88 mutation anlysis helps define nodal lymphoplasmacytic lymphoma. Mod Pathol. 2014. [Epub ahead of print].
-
(2014)
Mod Pathol.
-
-
Hamadeh, F.1
Macnamara, S.P.2
Aguilera, N.S.3
|